Jenkins Annalisa — SEC Form 4 filings
SEC reporting owner CIK 1639481. 13 Form 4 filings on record with FilingPulse; latest filed 2026-04-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-05 to 2026-04-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | Director | 3 | — | — | 6 |
| COMPASS Pathways plc (CMPS) | Director | 5 | — | — | 5 |
| Skye Bioscience, Inc. (SKYE) | Director | 5 | — | — | 5 |
Form 4 filings — Jenkins Annalisa
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-02 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 66,000 (derivative) @ $0 · Grant/award (A): 106,848 (derivative) | EDGAR |
| 2026-02-09 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 55,000 (derivative) @ $0 · Grant/award (A): 15,243 (derivative) | EDGAR |
| 2024-10-30 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | COMPASS Pathways plc (CMPS) | Tax withholding (F): 161 @ $6.88 | EDGAR |
| 2024-05-13 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | COMPASS Pathways plc (CMPS) | Tax withholding (F): 211 @ $8.48 | EDGAR |
| 2024-03-04 | 4 | Skye Bioscience, Inc. (SKYE) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 45,000 (derivative) @ $0 · Grant/award (A): 14,947 (derivative) | EDGAR |
| 2024-02-05 | 4 | COMPASS Pathways plc (CMPS) | Tax withholding (F): 175 @ $11.34 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1639481 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →